Monthly Rebalancing
EUR
Moderate Risk
0.5yr backtest

Performance Summary

Total Return+13.72%
Annualized Return+32.04%
Volatility+13.04%
Sharpe Ratio2.30
Max Drawdown+6.21%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified global equity portfolio with 80% US tech via Nasdaq 100 and 20% quality dividends for balanced growth.
AssetTypeAllocationTER
SPYI.XETRA
SPDR MSCI All Country World Investable Market UCITS ETF (Acc)IE00B3YLTY66
ETF
40.0%0.17%
SXRV.XETRA
iShares Nasdaq 100 UCITS ETF (Acc)IE00B53SZB19
ETF
40.0%0.3%
LDGL.XETRA
L&G Global Quality Dividends UCITS ETF USD DistIE0005AJA0P1
ETF
20.0%0.29%
Total100.0%0.25%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €11,372.18
Histogram of Monthly Returns
The portfolio had a positive return during 4 of the 7 months (57%)
Monthly Returns Heatmap
Best month: +10.2% • Worst month: -4.9% • Best year: 2026 (+13.7%) • Worst year: 2026 (+13.7%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-1.8%+1.3%-4.9%+10.2%+7.5%+1.7%-0.2%-----+13.7%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +6.21% • The longest drawdown period lasted for 1 month and was between February 2026 and April 2026. It reached a trough of -6.2%.

Dividend Income

Summary
This portfolio contains 1 distributing ETF (20.0% of total allocation)

Total Dividends Received

31.20

5 payments

Dividend Yield

0.65%

(annualized)

Avg Per Payment

6.24

per event

All dividends are automatically reinvested at the payment date. The portfolio value shown includes the compounding effect of dividend reinvestment.

Annual Breakdown
Dividend income per calendar year
YearDividends
202631.19
Total31.20

Detailed Metrics

Returns
Total Return
+13.72%
Annualized Return
+32.04%
Avg Monthly Return
+1.97%
Risk
Volatility (Annual)
+13.04%
Max Drawdown
+6.21%
Positive Months
57%
Average Drawdown
-1.7%
Risk-Adjusted
Sharpe Ratio
2.30
Risk-free rate: 2.0%
Sortino Ratio
2.51
Downside risk adjusted
Return/Volatility
2.46
Calmar Ratio
5.16
Return/Max Drawdown
Ulcer Index
1.90
Drawdown depth & duration
Martin Ratio
0.16
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
11,372.18
Backtest Period
2026-01-15 to 2026-07-03
0.5 years
Rebalancing
monthly
Base Currency
EUR
Teste 4 | +32.0% CAGR | ETF Backtest